Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

TEAM-NB Paper Offers Guidance For Manufacturers On IVDR Technical Files

Executive Summary

What do notified bodies designated under the EU In Vitro Diagnostics Regulation expect to see in manufacturers’ technical documentation during conformity assessments? A new TEAM-NB position paper helps companies through this process.

You may also be interested in...



Trade Body Updates Guidance On Meeting IVDR Clinical Evidence Requirements

Fulfilling performance evaluation obligations under the EU In Vitro Diagnostics Regulation can be confusing for manufacturers and particularly SMEs. Trade body MedTech Europe explains why defining the intended purpose of a product is a good place to start.

Another Notified Body Designation Coming Down The Line Under The EU MDR

With two IVD Regulation notified body designations in the last week, there should be one more notified body listed under the Medical Device Regulation designation shortly. But then there is likely to be a gap.

Total Number Of IVD Regulation Designations Reaches 10

Two EU IVDR notified bodies have now been designated this week. NSAI of Ireland has been designated as a notified body under the IVD Regulation, the tenth under the EU’s IVDR, and is specializing in self-testing.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT147681

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel